118 related articles for article (PubMed ID: 370021)
21. [Clinical experience with cephradine].
Ughy E
MMW Munch Med Wochenschr; 1977 Aug; 119(34):1093-4. PubMed ID: 408658
[No Abstract] [Full Text] [Related]
22. [Comparative results of cephacetrile with cefazolin in complicated urinary tract infections by means of double-blind trials (author's transl)].
Ishigami J; Mita T; Tanikaze S; Fujii A; Kuroda M
Jpn J Antibiot; 1976 Dec; 29(12):1052-69. PubMed ID: 796485
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
Fu KP; Hetzel N; Gregory FJ; Hung PP
J Antimicrob Chemother; 1987 Oct; 20(4):541-6. PubMed ID: 3680089
[TBL] [Abstract][Full Text] [Related]
24. [Clinical experience with cephradine injection in urinary tract infections (author's transl)].
Unno R; Yamamoto Y
Jpn J Antibiot; 1976 Nov; 29(11):979-84. PubMed ID: 794525
[No Abstract] [Full Text] [Related]
25. Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics.
Mattie H; van Dokkum AM; Brus-Weijer L; Krul AM; van Strijen E
J Infect Dis; 1990 Sep; 162(3):717-22. PubMed ID: 2143771
[TBL] [Abstract][Full Text] [Related]
26. [Cephradine in urology].
Hutschenreiter G; Klippel KF
MMW Munch Med Wochenschr; 1977 Nov; 119(47):1539-40. PubMed ID: 414092
[No Abstract] [Full Text] [Related]
27. [Clinical results with cephradine (CED) (author's transl)].
Adachi T
Jpn J Antibiot; 1976 Nov; 29(11):963-7. PubMed ID: 1003680
[No Abstract] [Full Text] [Related]
28. A preliminary report on cephradine.
Leary WP; Asmal AC; Lockett CJ; Bima B
S Afr Med J; 1975 Aug; 49(33):1356-8. PubMed ID: 1098181
[TBL] [Abstract][Full Text] [Related]
29. [Correlation between antibacterial activity of some cephalosporins and pharmacokinetic properties "in vitro" (author's transl)].
Tamassia V; Meinardi G; Grasso S; de Carneri I
Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():785-92. PubMed ID: 400257
[TBL] [Abstract][Full Text] [Related]
30. [Progress in antibacterial chemotherapy].
Naumann P; Rosin H
Verh Dtsch Ges Inn Med; 1978; (84):427-38. PubMed ID: 369199
[No Abstract] [Full Text] [Related]
31. Prophylactic antibiotics in prosthetic implant surgery.
Cunha BA; Quintiliani R
Conn Med; 1979 Jun; 43(6):344-6. PubMed ID: 467045
[No Abstract] [Full Text] [Related]
32. The impact of revised CLSI cefazolin breakpoints on the clinical outcomes of Escherichia coli bacteremia.
Wang KC; Liu MF; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2016 Oct; 49(5):768-774. PubMed ID: 26493889
[TBL] [Abstract][Full Text] [Related]
33. Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients.
Hobbs AL; Shea KM; Daley MJ; Huth RG; Jaso TC; Bissett J; Hemmige V
J Antimicrob Chemother; 2016 Jun; 71(6):1665-71. PubMed ID: 26983859
[TBL] [Abstract][Full Text] [Related]
34. [Application of parenteral cephradine in urinary tract infections (author's transl)].
Saito I; Miyamura R; Ban Y; Kawada Y
Jpn J Antibiot; 1976 Nov; 29(11):973-8. PubMed ID: 1003682
[TBL] [Abstract][Full Text] [Related]
35. Cephradine in the treatment of chronic recurrent infections of the urinary tract.
Wurth GH; Clarke TK
Curr Med Res Opin; 1976; 4(2):139-43. PubMed ID: 1277882
[TBL] [Abstract][Full Text] [Related]
36. Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
McClure JT; Rosin E
Am J Vet Res; 1998 Jun; 59(6):750-5. PubMed ID: 9622746
[TBL] [Abstract][Full Text] [Related]
37. [Cefazolin content in the gall bladder (author's transl)].
Greif S; Forche G; Kratochvil P
Wien Klin Wochenschr; 1977 Feb; 89(3):89-90. PubMed ID: 836611
[TBL] [Abstract][Full Text] [Related]
38. Cefazolin.
Quintiliani R; Nightingale CH
Ann Intern Med; 1978 Nov; 89(5 Pt 1):650-6. PubMed ID: 362999
[TBL] [Abstract][Full Text] [Related]
39. Therapy of infections with cefazolin.
Schreiner A; Digranes A; Hamre E; Nygaard H
Chemotherapy; 1976; 22(6):381-9. PubMed ID: 821726
[TBL] [Abstract][Full Text] [Related]
40. In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli.
Monogue ML; Nicolau DP
Antimicrob Agents Chemother; 2016 Dec; 60(12):7527-7529. PubMed ID: 27799205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
